Evidence map›Paper›PMID 22006909›Full record

ArticlePhilosophical transactions. Series A, Mathematical, physical, and engineering sciences2011

In vivo Cerenkov luminescence imaging: a new tool for molecular imaging.

Gregory S Mitchell, Ruby K Gill, David L Boucher, Changqing Li, Simon R Cherry

Open access · greenAbstract read
In one paragraph

Article in Philosophical transactions. Series A, Mathematical, physical, and engineering sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 160 citations in OpenAlex.

  1. Current Status of Cherenkov-Based Gamma Detectors for TOF-PET and Proton Range Verification.IEEE transactions on radiation and plasma medical sciences · 2026
    Article
  2. Review
  3. Optical (Cherenkov) dosimetry to unravel the radiobiological effects of radioisotope based therapy.European journal of nuclear medicine and molecular imaging · 2025
    Article
  4. Hybrid Monte Carlo model for efficient tissue Cherenkov emission estimation to assess changes from beam size, energy and incidence.Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB) · 2025
    Article
  5. Exploring innovative strides in radiolabeled nanoparticle progress for multimodality cancer imaging and theranostic applications.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Review
  6. Article
  7. Review
  8. Detection of Shortwave-Infrared Cerenkov Luminescence from Medical Isotopes.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  9. In vivo molecular imaging in preclinical research.Laboratory animal research · 2022
    Review
  10. Article
  11. Article
  12. Radiopharmaceutical and EuJournal of nanobiotechnology · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Fluorescence Emission Triggered by RadioactivePhysical review applied · 2020
    Article
  18. Cerenkov luminescence and PET imaging ofPhysics in medicine and biology · 2020
    Article
  19. Review
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Gregory S MitchellDepartment of Biomedical Engineering, and Center for Molecular and Genomic Imaging, University of California at Davis, , One Shields Avenue, Davis, CA 95616, USA. gsmitchell@ucdavis.edu
Ruby K Gill
David L Boucher
Changqing Li
Simon R Cherry
University of California, Davis · US

Funding

Staff InvestigatorsP30CA093373 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI Laura Marcu · 2002 to 2026
$84.9M
In Vivo Optical Imaging of Beta-Emitting Radionuclides using Cerenkov RadiationR21CA143098 · NCI · UNIVERSITY OF CALIFORNIA AT DAVIS · PI CHERRY, SIMON R · 2010 to 2011
$360k
NCI NIH HHS P30 CA093373NCI NIH HHS R21 CA143098
6 · The paper itself

Abstract

Cerenkov radiation is a phenomenon where optical photons are emitted when a charged particle moves faster than the speed of light for the medium in which it travels. Recently, we and others have discovered that measurable visible light due to the Cerenkov effect is produced in vivo following the administration of β-emitting radionuclides to small animals. Furthermore, the amounts of injected activity required to produce a detectable signal are consistent with small-animal molecular imaging applications. This surprising observation has led to the development of a new hybrid molecular imaging modality known as Cerenkov luminescence imaging (CLI), which allows the spatial distribution of biomolecules labelled with β-emitting radionuclides to be imaged in vivo using sensitive charge-coupled device cameras. We review the physics of Cerenkov radiation as it relates to molecular imaging, present simulation results for light intensity and spatial distribution, and show an example of CLI in a mouse cancer model. CLI allows many common radiotracers to be imaged in widely available in vivo optical imaging systems, and, more importantly, provides a pathway for directly imaging β(-)-emitting radionuclides that are being developed for therapeutic applications in cancer and that are not readily imaged by existing methods.

Indexed as

AnimalsCell Line, TumorDisease Models, AnimalHumansKineticsLightLuminescenceMiceMice, SCIDMolecular ImagingMonte Carlo MethodNeoplasmsNeoplasm TransplantationOptics and PhotonicsRadioisotopesRefractometryRadioisotopes

Identifiers

PMID22006909
PMCPMC3263789
OpenAlexW2106618401

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.